Adjuvant and neoadjuvant therapies in melanoma.
In: ESMO open, Jg. 5 (2020-07-01), Heft 4
Online
editorialOpinion
Zugriff:
Click here to listen to the Podcast.
Competing Interests: Competing interests: TA receives personal fees and travel support from Bristol-Myers Squibb and Novartis, and personal fees from Pierre Fabre and CeCaVa.
(© Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.)
Titel: |
Adjuvant and neoadjuvant therapies in melanoma.
|
---|---|
Autor/in / Beteiligte Person: | Lim, KHJ ; Amaral, T |
Link: | |
Zeitschrift: | ESMO open, Jg. 5 (2020-07-01), Heft 4 |
Veröffentlichung: | 2021 : [London] : Elsevier ; <i>Original Publication</i>: London : BMJ, [2016]-, 2020 |
Medientyp: | editorialOpinion |
ISSN: | 2059-7029 (electronic) |
DOI: | 10.1136/esmoopen-2020-000849 |
Schlagwort: |
|
Sonstiges: |
|